Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer

Table 1 General situation of the patients, n (%)

Influencing factors	D-TACE (15 cases)	C-TACE (58 cases)	t/χ2 value	P value
Age (yr)	57.3 ± 11.5	59.9 ± 10.7	-0.8361	0.406
The longest tumor size before surgery (mm)	102.7 ± 44.4	75.0 ± 34.1	2.6261	0.011
Gender			1.907	0.167
Female	1 (6.7)	13 (22.4)
Male	14 (93.3)	45 (77.6)
Whether infected with HBV			11.317	0.0008
No	9 (60.0)	10 (17.2)
Yes	6 (40.0)	48 (82.8)
Whether there is liver cirrhosis			3.137	0.069
No	9 (60.0)	18 (31.0)
Yes	6 (40.0)	40 (69.0)
Is there a portal vein tumor thrombus			0.602	0.438
No	13 (86.7)	45 (77.6)
Yes	2 (13.3)	13 (22.4)
ECOG stamina score			3.769	0.152
0 points	2 (13.3)	13 (22.4)
1points	9 (60.0)	40 (69.0)
2points	4 (26.7)	5 (8.6)
Child-Pugh classification			1.668	0.196
A	6 (40.0)	34 (58.6)
B	9 (60.0)	24 (41.4)
Number of tumors			1.237	0.744
1	3 (20.0)	7 (12.1)
2	1 (6.7)	2 (3.4)
3	0 (0.0)	1 (1.7)
Multiple (> 3)	11 (73.3)	48 (82.8)
Barcelona staging			0.434	0.510
B	9 (60)	40 (69)
C	6 (40)	18 (31)

¹Result of t test.

ECOG: The Eastern Cooperative Oncology Group; D-TACE: Drug-loaded microspheres transcatheter arterial chemoembolization; C-TACE: Traditional/conventional transcatheter arterial chemoembolization.